SCHEMBL1084445

SCHEMBL1084445

Cc1ccc(F)c(-c2nc(N(C)C)c3ccccc3n2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 13/20 0.62
CYP1A2 P05177 12/20 0.62
CLK4 Q9HAZ1 8/20 0.62
CYP2C19 P33261 8/20 0.62
TSHR P16473 7/20 0.62
MAPK1 P28482 2/20 0.62
CYP3A4 P08684 10/20 0.58
ALDH1A1 P00352 7/20 0.58
HSD17B10 Q99714 6/20 0.58
LMNA P02545 5/20 0.58
ALOX15 P16050 5/20 0.58
USP2 O75604 4/20 0.58
TP53 P04637 2/20 0.58
CYP2C9 P11712 6/20 0.56
MAPT P10636 3/20 0.52
GLA P06280 2/20 0.52
KDM4E B2RXH2 2/20 0.52
HPGD P15428 2/20 0.52
HIF1A Q16665 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084479 0.88 CYP2D6 (0.63) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL937501 0.84 CYP2D6 (0.70) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL938450 0.84 CYP2D6 (0.62) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL939163 0.82 CYP2D6 (0.74) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1084222 0.81 CYP2D6 (0.62) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1083778 0.80 CYP2D6 (0.63) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1084020 0.79 CYP2D6 (0.56) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL1083964 0.78 CYP2D6 (0.65) CYP2D6CYP1A2CLK4CYP2C19TSHR
SCHEMBL20937832 0.76 L3MBTL1 (0.50) CYP1A2CLK4CYP2C19TSHRMAPK1
SCHEMBL1084265 0.76 CYP2D6 (0.61) CYP2D6CYP1A2CLK4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed